2i3c
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:2i3c.gif|left|200px]] | + | [[Image:2i3c.gif|left|200px]] |
| - | + | ||
| - | '''Crystal Structure of an Aspartoacylase from Homo Sapiens''' | + | {{Structure |
| + | |PDB= 2i3c |SIZE=350|CAPTION= <scene name='initialview01'>2i3c</scene>, resolution 2.800Å | ||
| + | |SITE= | ||
| + | |LIGAND= <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> and <scene name='pdbligand=PO4:PHOSPHATE ION'>PO4</scene> | ||
| + | |ACTIVITY= [http://en.wikipedia.org/wiki/Aspartoacylase Aspartoacylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.1.15 3.5.1.15] | ||
| + | |GENE= ASPA, ACY2, ASP ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | ||
| + | }} | ||
| + | |||
| + | '''Crystal Structure of an Aspartoacylase from Homo Sapiens''' | ||
| + | |||
==Overview== | ==Overview== | ||
| Line 10: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | 2I3C is a [ | + | 2I3C is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2I3C OCA]. |
==Reference== | ==Reference== | ||
| - | Structure of aspartoacylase, the brain enzyme impaired in Canavan disease., Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr, Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:[http:// | + | Structure of aspartoacylase, the brain enzyme impaired in Canavan disease., Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr, Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17194761 17194761] |
[[Category: Aspartoacylase]] | [[Category: Aspartoacylase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 30: | Line 39: | ||
[[Category: aspartoacylase family]] | [[Category: aspartoacylase family]] | ||
[[Category: canavan disease]] | [[Category: canavan disease]] | ||
| - | [[Category: center for eukaryotic structural | + | [[Category: center for eukaryotic structural genomic]] |
[[Category: cesg]] | [[Category: cesg]] | ||
[[Category: n-acetyl-l-aspartate]] | [[Category: n-acetyl-l-aspartate]] | ||
| Line 37: | Line 46: | ||
[[Category: zinc-dependent hydrolase]] | [[Category: zinc-dependent hydrolase]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 17:25:02 2008'' |
Revision as of 15:25, 20 March 2008
| |||||||
| , resolution 2.800Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | and | ||||||
| Gene: | ASPA, ACY2, ASP (Homo sapiens) | ||||||
| Activity: | Aspartoacylase, with EC number 3.5.1.15 | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Crystal Structure of an Aspartoacylase from Homo Sapiens
Contents |
Overview
Aspartoacylase catalyzes hydrolysis of N-acetyl-l-aspartate to aspartate and acetate in the vertebrate brain. Deficiency in this activity leads to spongiform degeneration of the white matter of the brain and is the established cause of Canavan disease, a fatal progressive leukodystrophy affecting young children. We present crystal structures of recombinant human and rat aspartoacylase refined to 2.8- and 1.8-A resolution, respectively. The structures revealed that the N-terminal domain of aspartoacylase adopts a protein fold similar to that of zinc-dependent hydrolases related to carboxypeptidases A. The catalytic site of aspartoacylase shows close structural similarity to those of carboxypeptidases despite only 10-13% sequence identity between these proteins. About 100 C-terminal residues of aspartoacylase form a globular domain with a two-stranded beta-sheet linker that wraps around the N-terminal domain. The long channel leading to the active site is formed by the interface of the N- and C-terminal domains. The C-terminal domain is positioned in a way that prevents productive binding of polypeptides in the active site. The structures revealed that residues 158-164 may undergo a conformational change that results in opening and partial closing of the channel entrance. We hypothesize that the catalytic mechanism of aspartoacylase is closely analogous to that of carboxypeptidases. We identify residues involved in zinc coordination, and propose which residues may be involved in substrate binding and catalysis. The structures also provide a structural framework necessary for understanding the deleterious effects of many missense mutations of human aspartoacylase.
Disease
Known diseases associated with this structure: Canavan disease OMIM:[608034]
About this Structure
2I3C is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease., Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr, Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761
Page seeded by OCA on Thu Mar 20 17:25:02 2008
Categories: Aspartoacylase | Homo sapiens | Single protein | Bingman, C A. | Bitto, E. | CESG, Center for Eukaryotic Structural Genomics. | Jr., G N.Phillips. | Mccoy, J G. | Wesenberg, G E. | PO4 | ZN | Acy2 | Aminoacylase-2 | Aspa | Aspartoacylase family | Canavan disease | Center for eukaryotic structural genomic | Cesg | N-acetyl-l-aspartate | Protein structure initiative | Psi | Zinc-dependent hydrolase
